Finally, we examined whether the AMPKα1/PHD2/HIFα/hepcidin/ferroportin axis in vivo identified was clinically relevant to iron dyshomeostasis in anaemia of advanced malignant tumour. The gene discussed is EGLN1; the disease is cancer.